Search filters

Filters
Clear All

Phase

  • 11
  • 38
  • 28
  • 46
  • 6
  • 50
  • 9
  • 278
  • 490
  • 158
  • 4
  • 31
  • 457
  • 486
  • 6
  • 4
  • 488

Found 492 Barrett's Esophagus trials

A listing of Barrett's Esophagus medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Sort by:
UPCC 07623 Effect of Immune Checkpoint Inhibitors on Coronary Microvasculature
18 years or above
All genders
Observational
The purpose of this study is to investigate the effects of immune checkpoint inhibitors (ICI) on the heart and circulatory system in patients with breast cancer or non-small cell lung cancer. This study focuses on understanding how these medications, which are used in cancer treatment, might impact heart health. An …
18 years or above
All genders
Phase 3
Interventional
This study investigates the efficacy and safety of an investigational medication in combination with chemotherapy for treating individuals with metastatic HER2-positive breast cancer. Participants in this study have previously been treated with a specific medication called T-DXd but have either not responded or cannot tolerate it.Participants will be randomly assigned …
99 years or below
All genders
This study investigates hematopoietic cell transplantation and other cellular therapies, as well as marrow toxic injuries. The purpose is to collect observational data to better understand these conditions.The study will gather data from participants who undergo routine care, without altering their treatments. This observational study aims to create a comprehensive …
18 years or above
All genders
Phase 1
Interventional
This study investigates a potential treatment for Acute Myeloid Leukemia (AML). The purpose of this study is to explore the use of a modified stem cell transplant combined with engineered T cells, known as chimeric antigen receptor (CAR) T cells, to target and attack leukemia cells. CAR T cells are …
18 years or above
All genders
Interventional
The purpose of this study is to investigate different biopsy strategies during colonoscopy for patients with Inflammatory Bowel Disease (IBD). This study focuses on two methods: the limited biopsy strategy, which involves taking fewer random biopsies, and the random biopsy strategy, which involves taking more frequent biopsies throughout the colon. …
60 years or above
All genders
Interventional
This study investigates the impact of a supervised exercise program on outcomes for older adults undergoing allogeneic hematopoietic cell transplantation (HCT). The purpose of this study is to see if such an exercise program can be successfully implemented.Participants will be divided into two study arms: Cohort A (Prehab) and Cohort …
Product Surveillance Registry (PSR) Platform - Aortic, Peripheral & Venous (APV)
18 years - 100 years
All genders
Phase 4
This post-market registry serves as an ongoing source of product performance, patient safety, and clinical outcomes for a variety of different products. The research design allows products to be added once they are released on the market. Patients are enrolled and followed according to their care provider’s normal care routine.
99 years or below
All genders
This is an OLE for all subjects we currently have enrolled in BI 1305-0014 and 1305-0023. Subjects will be on either 9 mg or 18 mg of IP based on results from the current studies. Procedures involve safety labs, lung function testing, clinical labs, ECGs, PEs, AE collection.
99 years or below
All genders
The objectives of the study are to quantify cardiac metabolic consumption of approximately 100 metabolites, measurable by quantitative mass spectrometry. The metabolic consumption of the heart will be measured in patients with heart failure who are simultaneously undergoing invasive hemodynamic assessment via right heart catheterization. Quantitative measurement of metabolites. None.
99 years or below
All genders
This study's primary objective will be to create a database of lung cancer patients treated with immunotherapy agents and to access Remnant (left-over) tissue collected from clinically-indicated procedures/surgery for analyses, to determine factors that predict response to immunotherapy, and/or the toxicity prole of patients treated with immunotherapy.
271 - 280 of 492